CLY

CLINDAMYCIN

Find entries where: CLY

is present as a standalone ligand in 6 entries

Find related ligands:

Chemical Component Summary
Name	CLINDAMYCIN
Identifiers	(1R,2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-oxan-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide
Formula	C₁₈ H₃₃ Cl N₂ O₅ S
Molecular Weight	424.983
Type	NON-POLYMER
Isomeric SMILES	CCC[C@@H]1C[C@H]([N@@](C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl
InChI	InChI=1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)/t9-,10+,11-,12+,13-,14+,15+,16+,18+/m0/s1
InChIKey	KDLRVYVGXIQJDK-AWPVFWJPSA-N

Chemical Details
Formal Charge	0
Atom Count	60
Chiral Atom Count	9
Bond Count	61
Aromatic Bond Count	0

Drug Info: DrugBank

DrugBank ID	DB01190
Name	Clindamycin
Groups	approved vet_approved
Description	Clindamycin is a semi-synthetic lincosamide antibiotic used in the treatment of a variety of serious infections due to susceptible microorganisms[L11599,L11596] as well as topically for acne vulgaris.[L11593] It has a relatively narrow spectrum of activity that includes anaerobic bacteria as well as gram-positive cocci and bacilli and gram-negative bacilli.[A190621] Interestingly, clindamycin appears to carry some activity against protozoans, and has been used off-label in the treatment of toxoplasmosis, malaria, and babesiosis.[A190657] Clindamycin is derived from, and has largely replaced, [lincomycin], a naturally occurring lincosamide and the eponymous member of this antibiotic class, due to its improved properties over the parent compound. The name lincomycin is derived from Lincoln, Nebraska, where it was first isolated from _Streptomyces lincolnensis_ found in a soil sample.[A190621]
Synonyms	Clindamycin palmitate hydrochloride Clindamycinum Clindamycine Clindamycin phosphate 7-CDL Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside Clindamicina Clindamycin 7(S)-Chloro-7-deoxylincomycin Clindamycin hydrochloride
Brand Names	CLIN-LIDO-Single Use Kit Cabtreo Clindamycin phosphate and benzoyl peroxide Clindamycin HCL Clindesse Imiquimod 5% / Levocetirizine Dihydrochloride 1% / Tretinoin 0.05% Clindamycin Phosphate and Benzoyl Peroxide Clindamycin Phosphate and Benzoyl Peroxide Taro-clindamycin Clindamycine-300 Clindamycin 1% / Niacinamide 2% / Tazarotene 0.05% Clindamycin 1% / Niacinamide 4% Clindamycin Phoaphate Topical Solution, 1% Auro-clindamycin Clindamycin Phosphate Topical Solution USP, 1% Cleocin Phosphate Cleocin Hydrochloride Clindamycin Injection Sdz Clindamycin Palmitate Hydrochloride (Pediatric) Dalacin Vaginal Cream Clindamycin Injection In 5% Dextrose Clindamycin 1% / Niacinamide 4% / Tretinoin 0.05% Benzoyl Peroxide 2.5% / Clindamycin 1% / Niacinamide 4% Dalacin C Flavoured Granules Clindamycin phosphate Taro-clindamycin/benzoyl Peroxide Gel Clindamycin Phosphate and Tretinoin Taro-benzoyl Peroxide / Clindamycin Kit Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Spironolactone 2% / Tretinoin 0.025% Clindacin PAC Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 4% Benzoyl Peroxide 2.5% / Clindamycin 1% / Niacinamide 2% / Tretinoin 0.025% Clinda-Derm Dalacin C 150 mg Clindamycin 1% / Niacinamide 4% / Tretinoin 0.025% Clinda-T Clindets NuCaraRXPAK Clindacin Clindap-T CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric) ClindaMax Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Tretinoin 0.1% Nra-clindamycin Clindamycin Palmitate Hydrochloride Clindamycin Injection USP M-clindamycin Clindamycin and Benzoyl Peroxide Clindacin P Clindamycin Phosphate and Benzoyl Peroxide Cleocin Pediatric Clindamycin - Benzoyl Peroxide Benzoyl Peroxide 2.5%, Clindamycin Phosphate 1%, Niacinamide 2% / Tretinoin 0.05% Clindamycin Phoaphate Topical USP, 1% Ava-clindamycin Clindamycin 1% / Niacinamide 4% / Spironolactone 2% / Tretinoin 0.025% Benzoyl Peroxide 5% / Clindamycin1% / Niacinamide 2% / Tretinoin 0.025% Biacna Topical Gel Truemed Group LLC Onexton Ratio-clindamycin Capsules-150mg Neuac Evoclin Cleocin T Teva-clindamycin Adapalene 0.1% / Benzoyl Peroxide 2.5% / Clindamycin 1% Clindamycin Phoaphate Topical Solution USP, 1% Neuac Kit Cleocin Clindamycin Phosphate and Tretinoin Gel 1.2%/0.025% Clindamycin Palmitate Hydrochloride (pediatric) Ziana Adapalene 0.3% / Benzoyl Peroxide 2.5% / Clindamycin 1% Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Spironolactone 2% Dalacin T 1% Clindamycin IV Infusion ClindaReach Clindamycin Hydrochloride Ag-clindamycin Benzaclin Clindamycin 1% / Sodium Sulfacetamide Monohydrate 5% / Tretinoin 0.025% Clindamycin Phosphate 1.2% and Tretinoin 0.025% Priva-clindamycin Clindacin ETZ PMS-clindamycin Clindamycin Phosphate Topical Solution USP Clindavix Clindagel CLIN-Single Use Kit Clindamycin hydrochloride Clindoxyl Adv Gel Clindamycin Injection, USP Clindamax Riva-clindamycin Clindasol Clindamycin Phosphate Clindoxyl Gel Clindamycin 1% / Hydrocortisone 2.5% / Niacinamide 4% Med-clindamycin Clindamycin Phosphate and Tretinion Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Spironolactone 2% / Tretinoin 0.05% Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Tretinoin 0.05% Duac Veltin Mylan-clindamycin Clindamycin in 5 Percent Dextrose Clindamycin Cleocin Phosphate (0009-6582) (standalone) Apo-clindamycin Clindamycin Phosphate Injection USP Liq NuCaraClinPAK Acanya Dalacin C 300 mg Nu-clindamycin Xaciato Dalacin C Phosphate Clindamycine-150 Jamp Clindamycin Ratio-clindamycin Capsules - 300mg
Indication	In oral and parenteral formulations, clindamycin is indicated for the treatment of serious infections caused by susceptible anaerobic bacteria, as well as susceptible staphylococci, streptococci, and pneumococci.[L11599,L11602] Used topically, it is indicated for the treatment of acne vulgaris[L11593,L11611,L11605] and is available in combination with [benzoyl peroxide][L11584] or [tretinoin][L11590] for this purpose, or as a triple combination therapy with benzoyl peroxide and [adapalene].[L48666] Clindamycin is also indicated as a vaginal cream[L11596], suppository[L11608], or gel[L39416] for the treatment of bacterial vaginosis in non-pregnant females. Clindamycin is used for antimicrobial prophylaxis against _Viridans_ group streptococcal infections in susceptible patients undergoing oral, dental, or upper respiratory surgery, and may be used for prophylaxis against bacterial endocarditis in penicillin-allergic patients at high risk of these infections.[L11629]
Categories	Agents that produce neuromuscular block (indirect) Anti-Acne Preparations Anti-Acne Preparations for Topical Use Anti-Bacterial Agents Anti-Infective Agents Antibacterials for Systemic Use Antibiotics for Pneumocystis Pneumonia Antiinfectives for Systemic Use Antiinfectives for Treatment of Acne Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (moderate) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Decreased Sebaceous Gland Activity Dermatologicals Enzyme Inhibitors Genito Urinary System and Sex Hormones Glycosides Gynecological Antiinfectives and Antiseptics Lincomycins Lincosamide Antibacterial Lincosamides Macrolides Macrolides, Lincosamides and Streptogramins Neuromuscular Blockade Neurotoxic agents P-glycoprotein substrates Protein Synthesis Inhibitors Pyrrolidines
ATC-Code	D10AF01 J01FF01 D10AF51 G01AA10
CAS number	18323-44-9

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
50S ribosomal protein L1	MAKKGKKYQEAASKVDRTQHYSVEEAIKLAKETSIANFDASVEVAFRLGI...	unknown	inhibitor
Cytochrome P450 3A5	MDLIPNLAVETWLLLAVSLVLLYLYGTRTHGLFKRLGIPGPTPLPLLGNV...	unknown	substrate
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate,inhibitor
Alpha-1-acid glycoprotein 1	MALSWVLTVLSLLPLLEAQIPLCANLVPVPITNATLDQITGKWFYIASAF...	unknown	substrate
P-glycoprotein 1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown	substrate

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682